Hsbc Holdings PLC Regenxbio Inc. Transaction History

Hsbc Holdings PLC

  • $168 Billion
  • Q3 2024

A detailed history of Hsbc Holdings PLC transactions in Regenxbio Inc. stock. As of the latest transaction made, Hsbc Holdings PLC holds 36,507 shares of RGNX stock, worth $406,687. This represents 0.0% of its overall portfolio holdings.

Number of Shares
36,507
Previous 19,916 83.3%
Holding current value
$406,687
Previous $233,000 63.95%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$10.49 - $14.39 $174,039 - $238,744
16,591 Added 83.3%
36,507 $382,000
Q2 2024

Aug 12, 2024
BUY
$11.51 - $21.53 $62,027 - $116,025
5,389 Added 37.1%
19,916 $233,000
Q1 2024

May 15, 2024
SELL
$12.17 - $24.61 $165,731 - $335,138
-13,618 Reduced 48.39%
14,527 $306,000
Q4 2023

Feb 12, 2024
SELL
$12.89 - $20.82 $31,412 - $50,738
-2,437 Reduced 7.97%
28,145 $505,000
Q3 2023

Nov 13, 2023
SELL
$16.46 - $19.99 $113,392 - $137,711
-6,889 Reduced 18.38%
30,582 $503,000
Q2 2023

Aug 11, 2023
BUY
$17.23 - $21.71 $110,116 - $138,748
6,391 Added 20.56%
37,471 $749,000
Q1 2023

May 15, 2023
BUY
$18.08 - $24.55 $263,696 - $358,061
14,585 Added 88.42%
31,080 $587,000
Q4 2022

Feb 14, 2023
BUY
$20.4 - $24.73 $87,230 - $105,745
4,276 Added 34.99%
16,495 $374,000
Q3 2022

Nov 14, 2022
BUY
$22.29 - $35.04 $84,991 - $133,607
3,813 Added 45.36%
12,219 $328,000
Q2 2022

Aug 11, 2022
SELL
$19.35 - $35.04 $21,807 - $39,490
-1,127 Reduced 11.82%
8,406 $210,000
Q1 2022

May 16, 2022
BUY
$24.62 - $34.31 $234,702 - $327,077
9,533 New
9,533 $321,000
Q3 2021

Nov 12, 2021
SELL
$29.09 - $45.68 $226,552 - $355,755
-7,788 Closed
0 $0
Q2 2021

Aug 13, 2021
SELL
$32.46 - $40.48 $203,686 - $254,011
-6,275 Reduced 44.62%
7,788 $302,000
Q1 2021

May 14, 2021
BUY
$33.61 - $49.95 $472,657 - $702,446
14,063 New
14,063 $479,000
Q3 2020

Nov 12, 2020
SELL
$27.01 - $40.26 $1.2 Million - $1.79 Million
-44,578 Closed
0 $0
Q2 2020

Aug 14, 2020
BUY
$27.75 - $43.44 $1.24 Million - $1.94 Million
44,578 New
44,578 $1.64 Million
Q1 2020

May 15, 2020
SELL
$21.5 - $54.2 $113,584 - $286,338
-5,283 Closed
0 $0
Q4 2019

Feb 14, 2020
SELL
$34.54 - $44.87 $60,030 - $77,984
-1,738 Reduced 24.75%
5,283 $217,000
Q3 2019

Nov 14, 2019
BUY
$31.84 - $50.88 $28,114 - $44,927
883 Added 14.39%
7,021 $250,000
Q2 2019

Aug 13, 2019
BUY
$42.0 - $59.29 $34,818 - $49,151
829 Added 15.61%
6,138 $316,000
Q1 2019

May 15, 2019
BUY
$40.82 - $62.45 $216,713 - $331,547
5,309 New
5,309 $304,000

Others Institutions Holding RGNX

# of Institutions
197
Shares Held
43.2M
Call Options Held
104K
Put Options Held
478K
View Full List

About REGENXBIO Inc.

RGNX Quotes by TradingView
  • Ticker RGNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,230,000
  • Market Cap $482M
  • Description
  • REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...
More about RGNX
Track This Portfolio

Track Hsbc Holdings PLC Portfolio

Follow Hsbc Holdings PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Hsbc Holdings PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email